CXCL16 and rheumatoid arthritis: CXCR6/CXCL16 is highly expressed in the synovial tissue of rheumatoid arthritis (RA) patients, where it recruits T cells and monocytes to the inflamed joints, promoting the production of pro‐inflammatory cytokines that exacerbate joint inflammation and damage.